Page 906 - Adams and Stashak's Lameness in Horses, 7th Edition
P. 906

872   Chapter 7


            PSSM; however, the amount of starch and sugar can     Intramuscular injections of vitamin E and selenium
            vary widely, as can the type of fat. Not all of these feeds   are used in an attempt to prevent RER. Ensuring ade­
  VetBooks.ir  equine feed products is not listed on the feed tag, and   ciated with IM injections.
                                                               quate oral intake may prevent the muscle soreness asso­
            are equally effective.  At present, the NSC content of
                                                                  Some mares appear to exhibit signs of ER during
            consultation with the feed manufacturer is necessary to
            obtain this information. Nutritional support is available   estrus, and it may well be beneficial in these horses to
            through most feed manufacturers in designing an appro­  suppress estrus behavior using progesterone injections.
            priate diet. There are published peer‐reviewed studies to   Testosterone and anabolic steroids are used at race­
            show the beneficial effect of one commercial diet on   tracks to prevent signs of RER, but the efficacy has not
            both RER and PSSM. 55,59                           been evaluated.

            Supplements                                        Adjunct Therapies
              Horses require daily dietary supplementation with   Massage, myofascial release, mesotherapy, stretching,
            sodium and chloride either in the form of loose salt   and hot/cold therapy performed by experienced thera­
            (30–50 g/day)  or  a  salt block.  Additional  electrolyte   pists may be of benefit in individual cases of ER.
            supplementation is indicated in hot, humid conditions.
            Some  studies  suggest  that  electrolyte  imbalances,  as
            reflected by low urinary fraction excretion of sodium or   References
            high dietary excretion of phosphorus, may contribute   1.  Aleman M, Brosnan RJ, Williams DC, et al. Malignant hyperther­
            to ER, although others have not found a consistent    mia in a horse anesthetized with halothane. J  Vet Intern Med
            abnormality. 28,29                                    2005;19:363–366.
              A number of supplements are purported to decrease   2.  Aleman M, Nieto JE, Magdesian KG. Malignant hyperthermia
            lactic acid buildup in skeletal muscle of ER horses. These   associated with ryanodine receptor 1 (C7360G) mutation in
                                                                  Quarter Horses. J Vet Intern Med 2009;23:329–334.
            include sodium bicarbonate, B vitamins, branched‐chain   3.  Annandale EJ, Valberg SJ, Essen‐Gustavsson B. Effects of submax­
            amino acids, and dimethylglycine. Because lactic acido­  imal exercise on adenine nucleotide concentrations in skeletal
            sis is no longer implicated as a cause for ER, it is difficult   muscle fibers of horses with polysaccharide storage myopathy.
                                                                  Am J Vet Res 2005;66:839–845.
            to find a rationale for their use.                  4.  Bain FT, Merritt AM. Decreased erythrocyte potassium concen­
                                                                  tration associated with exercise‐related myopathy in horses. J Am
                                                                  Vet Med Assoc 1990;196:1259–1261.
            Medications                                         5.  Baird JD, Valberg SJ, Anderson SM, et al. Presence of the glycogen
              Low  doses  of  acepromazine  prior  to  exercise  have   synthase 1 (GYS1) mutation causing type 1 polysaccharide stor­
            been used in RER horses prone to excitement. A dose of   age myopathy in continental European draught horse breeds. Vet
                                                                  Rec 2010;167:781–784.
            7 mg IV 20 minutes before exercise is reported to make   6.  Bedford HE, Valberg SJ, Firshman AM. Early diagnosis and treat­
            horses more relaxed and manageable.  Reserpine and    ment of muscle atrophy and weakness associated with vitamin E
                                             24
            fluphenazine, which have a longer duration of effect, are   deficiency. J Vet Intern Med 2010;24:712–712.
            also used for this purpose. Horses given fluphenazine   7.  Beech J, Fletcher JE, Lizzo F, et al. Effect of phenytoin on the clini­
                                                                  cal signs and in vitro muscle twitch characteristics in horses with
            may occasionally exhibit bizarre behavior. Use of tran­  chronic intermittent rhabdomyolysis and myotonia. Am J Vet Res
            quilizers may only be necessary when horses are in their   1988;49:2130–2133.
            initial phase of training and accommodation to a new   8.  Beech J, Lindborg S, Fletcher JE, et  al. Caffeine contractures,
                                                                                                              2+
            environment because they obviously cannot compete on   twitch characteristics and the threshold for Ca(2+)‐induced Ca
                                                                  release in skeletal muscle from horses with chronic intermittent
            these medications.                                    rhabdomyolysis. Res Vet Sci 1993;54:110–117.
              Dantrolene sodium acts to decrease release of cal­  9.  Borgia L, Valberg S, McCue M, et al. Glycaemic and insulinaemic
            cium from the calcium release channel in skeletal mus­  responses to feeding hay with different non‐structural carbohydrate
            cle and is used to treat MH. Dantrolene given to horses   content in control and polysaccharide storage myopathy‐affected
                                                                  horses. J Anim Physiol Anim Nutr (Berl) 2011;95:798–807.
            with RER 90 minutes before exercise prevented abnor­  10.  Cardinet GH, Littrell JF, Freedland RA. Comparative investiga­
            mal elevations in CK following exercise.  A dose of   tions of serum creatine phosphokinase and glutamic‐oxaloacetic
                                                 52
            800 mg of dantrolene was given to  Thoroughbred       transaminase activities in equine paralytic myoglobinuria. Res Vet
            horses in the United Kingdom 1 hour prior to exercise   Sci 1967;8:219–226.
            and resulted in significantly lower post‐exercise CK   11.  Carlson GP. Medical problems associated with protracted heat
                                                                  and work stress in horses. In Proceedings of the Fifth  Annual
            activity than a placebo.  It must be given 60–90 min­  Meeting of the  Association of Equine Sports Medicine, Reno,
                                 19
            utes prior to exercise and horses do not need to be   Nevada, 1985;84–99.
            fasted. 51                                         12.  Carlson GP. Synchronous diaphragmatic flutter In Current
              Phenytoin (1.4–2.7 mg/kg PO BID) acts on a number   Therapy in Equine Medicine, 2nd ed. Robinson NE, ed.  W.B.
                                                                  Saunders Co., Philadelphia, 1987;485–486.
            of  ion  channels  within  muscle  and  nerves,  including   13.  Cole FL, Mellor DJ, Hodgson DR, et al. Prevalence and demo­
            sodium and calcium channels. Therapeutic levels vary,   graphic characteristics of exertional rhabdomyolysis in horses in
            so oral doses are adjusted by monitoring serum levels to   Australia. Vet Rec 2004;155:625–630.
                                                 7
            achieve 8 μg/mL and not to exceed 12 μg/mL.  Drowsiness   14.  Cumming WJKF JJ, Hudgson P, Mahon M. Color Atlas of Muscle
                                                                  Pathology. Mosby‐Wolfe, London, UK, 1994.
            and ataxia are evidence that the dose of phenytoin is too   15.  De La Corte FD, Valberg SJ, MacLeay JM, et al. Developmental
            high and the dose should be decreased by half. Initial   onset  of  polysaccharide  storage  myopathy  in  4 Quarter  Horse
            dosages start at 6–8 mg/kg orally twice a day for 3–5   foals. J Vet Intern Med 2002;16:581–587.
            days. If the horse still experiences rhabdomyolysis but is   16.  Divers TJ, Mohammed HO, Cummings JF, et al. Equine motor
                                                                  neuron disease: findings in 28 horses and proposal of a patho­
            not drowsy, the dose can be increased by 1 mg/kg incre­  physiological mechanism for the disease. Equine Vet J 1994;26:
            ments every 3–4 days.                                 409–415.
   901   902   903   904   905   906   907   908   909   910   911